HomeCompanies › NRXP

NRX Pharmaceuticals

Most recent annual filing: 2026-03-23

Catalyst timeline

2 trackedQuarter catalyst calendar →
  1. NRX-101 Ph3 start2026NRX-101 Ph3 start, 2026, routine
  2. NRX-100 ANDA FDA decisionNov 10, 2026NRX-100 ANDA FDA decision, Nov 10, 2026, thesis-defining

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (6 active programs)

Technology platforms

NMDA platform

NMDA receptor-targeting platform for central nervous system disorders including suicidal depression, chronic pain, and PTSD

Targets: NMDA

Biotech Distilled coverage (14)

Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.